
Terasom is an innovative, cutting-edge biomedical startup, founded in September 2019, in Prague, Czech Republic. Our main focus is developing novel exosomes-based early lung cancer diagnostic and therapy. We use specifically bioengineered exosomes as a “cell-free delivery cargos” to target adaptive immunity and eliminate lung primary tumors and metastases.
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.